Clinical Trials Browser

Interventional × dalotuzumab × Plasma cell × Clear all

NCT00701103 2018-08-08

Dose Escalation Trial of Dalotuzumab (MK-0646) in Advanced Solid Tumors and Multiple Myeloma (MK-0646-001)

Phase 1 Completed

80 enrolled 23 charts

Multiple Myeloma